Anthracycline disease free survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Lymph Nodes Heart Tumor Cells, Cultured Cells, Cultured Myocardium Bone Marrow Cell Line HL-60 Cells Myocytes, Cardiac

Organisms6

Streptomyces Nocardiaceae Micromonospora Nocardia Mice, Inbred BALB C Mice, Inbred C57BL

Diseases63

Breast Neoplasms Neoplasm Recurrence, Local Lymphatic Metastasis Carcinoma, Squamous Cell Neoplasm Invasiveness Recurrence Colorectal Neoplasms Carcinoma, Ductal, Breast Adenocarcinoma Carcinoma Liver Neoplasms Neoplasm Metastasis Leukemia P388 Lung Neoplasms Disease Progression Extravasation of Diagnostic and Therapeutic Materials Leukemia L1210 Heart Diseases Bone Neoplasms Lymphoma, Non-Hodgkin Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Cardiomyopathies Sarcoma Head and Neck Neoplasms Hodgkin Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Carcinoma, Hepatocellular Neoplasms Neoplasms, Germ Cell and Embryonal Pancreatic Neoplasms Osteosarcoma Neoplasm, Residual Brain Neoplasms Stomach Neoplasms Rectal Neoplasms Leukemia, Myeloid, Acute Uterine Cervical Neoplasms Mediastinal Neoplasms Melanoma Kidney Neoplasms Testicular Neoplasms Adenocarcinoma, Mucinous Colonic Neoplasms Leukemia, Promyelocytic, Acute Prostatic Neoplasms Soft Tissue Neoplasms Carcinoma, Renal Cell Nasopharyngeal Neoplasms Leukemia, Experimental Neoplasms, Glandular and Epithelial Glioblastoma Urinary Bladder Neoplasms Gastrointestinal Neoplasms Multiple Myeloma Skin Neoplasms Endometrial Neoplasms Leukemia Heart Failure Postoperative Complications Nausea Hematologic Diseases Alopecia

Chemicals and Drugs75

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Daunorubicin Doxorubicin Aclarubicin Carubicin Nogalamycin Tumor Markers, Biological Fluorouracil Razoxane Cyclophosphamide Receptor, erbB-2 Idarubicin Antineoplastic Agents Menogaril Receptors, Estrogen Epirubicin Vincristine Cisplatin Bridged Compounds Taxoids Etoposide Cardiotoxins Paclitaxel Methotrexate Intercalating Agents Free Radicals Receptors, Progesterone Deoxycytidine Cytarabine Neoplasm Proteins Prednisone Carboplatin Antibodies, Monoclonal Antibodies, Monoclonal, Humanized P-Glycoprotein Mitoxantrone Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Vinblastine Glycosides DNA Topoisomerases, Type II Antineoplastic Agents, Phytogenic Tamoxifen Antineoplastic Agents, Hormonal Verapamil Epothilones Antigens, Neoplasm Tumor Suppressor Protein p53 Organoplatinum Compounds Cinchona Alkaloids Leucovorin Ki-67 Antigen Anthraquinones Bleomycin Mitomycin Hydrazones Cardiotonic Agents RNA, Messenger DNA Ifosfamide Antibodies, Monoclonal, Murine-Derived Receptor, Epidermal Growth Factor Topoisomerase II Inhibitors Protein Kinase Inhibitors Liposomes Emodin Ketones DNA, Neoplasm Aminoacridines Angiogenesis Inhibitors Furans Multidrug Resistance-Associated Proteins Quinuclidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Disease-Free Survival Survival Rate Prognosis Neoplasm Staging Treatment Outcome Survival Analysis Retrospective Studies Combined Modality Therapy Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Chemotherapy, Adjuvant Radiotherapy, Adjuvant Immunohistochemistry Proportional Hazards Models Radiotherapy Dosage Multivariate Analysis Prospective Studies Immunoenzyme Techniques Predictive Value of Tests Risk Factors Neoadjuvant Therapy Drug Administration Schedule Remission Induction Salvage Therapy Neoplasm Grading Cohort Studies Chemoradiotherapy Radiotherapy Risk Assessment Lymph Node Excision Brachytherapy Actuarial Analysis Hematopoietic Stem Cell Transplantation Transplantation, Autologous Transplantation, Homologous Clinical Trials as Topic Dose Fractionation Reverse Transcriptase Polymerase Chain Reaction Randomized Controlled Trials as Topic Hepatectomy Magnetic Resonance Spectroscopy Radiotherapy, Intensity-Modulated Drug Screening Assays, Antitumor Mastectomy Tumor Burden Leukemia, Experimental Infusions, Intravenous Bone Marrow Transplantation Case-Control Studies Tissue Array Analysis Registries Radiotherapy, Conformal Heart Function Tests Drug Evaluation, Preclinical Peripheral Blood Stem Cell Transplantation Gene Expression Profiling Tomography, X-Ray Computed Echocardiography Chi-Square Distribution Drug Evaluation Probability Treatment Failure Analysis of Variance Risk Prostatectomy Statistics, Nonparametric Incidence

Phenomena and Processes26

Cell Survival Time Factors Gene Expression Regulation, Neoplastic Graft Survival Drug Resistance, Neoplasm Dose-Response Relationship, Drug Drug Resistance Apoptosis Mutation Drug Resistance, Multiple Molecular Structure Cell Proliferation Physicochemical Phenomena Fermentation Chemical Phenomena Signal Transduction Ventricular Function, Left Kinetics Structure-Activity Relationship Chi-Square Distribution Cell Division Probability DNA Damage Risk Oxidation-Reduction Oxidative Stress

Disciplines and Occupations3

Immunohistochemistry Chemistry, Physical Chemistry

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture1

Information Science6

Survival Rate Radiotherapy, Intensity-Modulated Registries Radiotherapy, Conformal Molecular Sequence Data Incidence

Named Groups1

Health Care27

Disease-Free Survival Survival Rate Treatment Outcome Survival Analysis Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Predictive Value of Tests Risk Factors Cohort Studies Age Factors Risk Assessment Actuarial Analysis Clinical Trials as Topic Randomized Controlled Trials as Topic Case-Control Studies Registries Chi-Square Distribution Probability Treatment Failure Analysis of Variance Risk Statistics, Nonparametric Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Disease-Free Survival Anthracyclines Survival Rate Naphthacenes Prognosis Antibiotics, Antineoplastic Neoplasm Staging Treatment Outcome Breast Neoplasms Survival Analysis Retrospective Studies Neoplasm Recurrence, Local Daunorubicin Combined Modality Therapy Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Doxorubicin Chemotherapy, Adjuvant Aclarubicin Carubicin Nogalamycin Tumor Markers, Biological Lymphatic Metastasis Radiotherapy, Adjuvant Cell Survival Immunohistochemistry Proportional Hazards Models Fluorouracil Razoxane Cyclophosphamide Radiotherapy Dosage Time Factors Receptor, erbB-2 Carcinoma, Squamous Cell Idarubicin Neoplasm Invasiveness Multivariate Analysis Antineoplastic Agents Recurrence Colorectal Neoplasms Menogaril Carcinoma, Ductal, Breast Receptors, Estrogen Adenocarcinoma Prospective Studies Carcinoma Liver Neoplasms Epirubicin Immunoenzyme Techniques Predictive Value of Tests Neoplasm Metastasis Leukemia P388 Risk Factors Gene Expression Regulation, Neoplastic Vincristine Cisplatin Survival Bridged Compounds Neoadjuvant Therapy Lung Neoplasms Drug Administration Schedule Remission Induction Taxoids Streptomyces Graft Survival Disease Progression Extravasation of Diagnostic and Therapeutic Materials Etoposide Cardiotoxins Salvage Therapy Neoplasm Grading Paclitaxel Leukemia L1210 Heart Diseases Methotrexate Intercalating Agents Free Radicals Drug Resistance, Neoplasm Cohort Studies Receptors, Progesterone Bone Neoplasms Lymphoma, Non-Hodgkin Deoxycytidine Age Factors Chemoradiotherapy Cytarabine Carcinoma, Non-Small-Cell Lung Dose-Response Relationship, Drug Ovarian Neoplasms Cardiomyopathies Neoplasm Proteins Sarcoma Radiotherapy Head and Neck Neoplasms Risk Assessment Prednisone Lymph Node Excision Brachytherapy Actuarial Analysis

No FAQ available that match "anthracycline disease free survival"